Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men. (Q44892371)

7 December 2017

title

Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men. (English)

1 reference

7 December 2017

Polyxeni Koutkia

1

1 reference

7 December 2017

Bridget Canavan

2

1 reference

7 December 2017

Jeff Breu

3

1 reference

7 December 2017

Michael L Johnson

4

1 reference

7 December 2017

Steven K Grinspoon

5

1 reference

7 December 2017

publication date

11 May 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 December 2017

published in

1 reference

7 December 2017

volume

287

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

E506-12

1 reference

Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ghrelin and leptin pulse discharge in fed and fasted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Influence of thyroid status and growth hormone deficiency on ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Sleep enhances nocturnal plasma ghrelin levels in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Serum Ghrelin Levels in Acromegaly: Effects of Surgical and Long-Acting Octreotide Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ghrelin, a novel placental-derived hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Weight loss increases circulating levels of ghrelin in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Peptides associated with hyperphagia in adults with Prader–Willi syndrome before and during GH treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ghrelin drives GH secretion during fasting in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

A role for ghrelin in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ghrelin immunoreactivity in human plasma is suppressed by somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Neurosteroid metabolism in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Hormone pulsatility discrimination via coarse and short time sampling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Somatostatin suppresses ghrelin secretion from the rat stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

A New Orphan Receptor Involved in Pulsatile Growth Hormone Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Ultradian Rhythmicity of Ghrelin Secretion in Relation with GH, Feeding Behavior, and Sleep-Wake Patterns in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Circulating ghrelin levels are decreased in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Analytical methods for evaluating episodic secretory activity within neuroendocrine axes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

Testing pulse detection algorithms with simulations of episodically pulsatile substrate, metabolite, or hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00548.2003

10.1152/AJPENDO.00548.2003

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference